Associate Professor, Department of Psychiatry and Behavioral Sciences
Director, HIV/AIDS Research Program
Director, Psychosomatic Fellowship Medicine Program
University of Washington at Harborview Medical Center
325 9th Avenue, PSB-5018
Box 359911
Seattle, WA 98104
(206) 991-6224
keegan@u.washington.edu
Educational Background:
- BA, Yale College- New Haven, CT, Molecular Biochemistry, 1983
- MD, University of Missouri School of Medicine- Columbia, MO, 1987
- MPH, University of Washington School of Public Health- Seattle, WA, Epidemiology, 1994
Current Research Interests:
Selected Publications:
- Bennett, M., Strachan, E., &Uldall, K. (2010). Development and initial validation of a brief screener for focused HIV prevention efforts. HIV Medicine, 11, 318–325.
- Bennett, M., Strachan, E., & Uldall, K. (2009). Examining predictors of HIV transmission risk behaviors reveals a potentially useful brief screener for focused prevention efforts. Journal of HIV Medicine.
- Mellins, C. A., Havens, J. F., McDonnell, C., Lichtenstein, C., Uldall, K. K., Chesney, M., et al. (2009). Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders. AIDS Care, 21, 168-177.
- Weaver, M. R., Conover, C. J., Proescholdbell, R. J., Arno, P. S., Ang, A., Uldall, K. K., et al. (2009). Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance use disorders. Journal of Mental Health Policy Economics, 12, 33-46.
- Crane, H.M., Grunfeld, C., Harrington, R.D., Uldall, K.K., Ciechanowski, P.S., Kitahata, M.M. (2008). Lipoatrophy among HIV-infected patients is associated with higher levels of depression than lipohypertrophy. HIV Medicine, 9(9), 780-786.
- Elliot, A.J., Russo, J., Bergam, K., Uldall, K.K., Claypoole, K., & Roy-Byrne, P.P. (1999). Antidepressant efficacy in HIV+ outpatients with major depression: an open trial of Nefazodone. Journal of Clinical Psychiatry, 60, 226-231.
- Elliot, A.J., Uldall, K.K., Bergam, K., Russo, J., Claypoole, K., & Roy-Byrne, P.P. (1998). Randomized, placebo-controlled trial of Paroxetine vs Imipramine in depressed HIV positive outpatients. American Journal of Psychiatry, 155, 367-372.